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Two different methods of lidocaine inhalation before diagnostic flexible bronchoscopy:
effects on post-bronchoscopy respiratory symptoms
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Background/aim: Use of topical anesthesia before flexible bronchoscopy for the evaluation of the upper airways prevents cough
and stridor during and after the procedure while reducing the need for sedation. In practice, lidocaine is the medication of choice
before bronchoscopy. There various types of nebulizers used for inhalation treatments. In this study, we compared the respiratory tract
symptoms after flexible bronchoscopy between children who received pre-procedure topical lidocaine with mesh or jet nebulizers.
Materials and methods: We enrolled 4–18 years old subjects that underwent flexible bronchoscopy due to treatment-resistant asthma
in this retrospective case-control study. Twenty subjects received topical lidocaine with jet nebulizers while 20 received it with mesh
nebulizers. Age, sex, duration of bronchoscopy, duration of anesthesia, time to awaken, and time to recovery were recorded as well as
cough and laryngospasm scores after flexible bronchoscopy.
Results: Severe cough after flexible bronchoscopy was not encountered in the mesh nebulizers group but was seen in 10% of the jet
nebulizers group (p = 0.027). On the other hand, age, sex, duration of bronchoscopy, duration of anesthesia, time to awaken, and
time to recovery were not significantly different between the mesh and jet nebulizer groups (p = 0.44, 0.34, 0.51, 0.88, 0.88, and 0.22,
respectively). Moreover, croup and laryngospasm scores between the two groups were similar (p = 0.62, 0.50 respectively). Cough score
was significantly worse jet nebulizers group (p = 0.03).
Conclusion: Topical lidocaine application with mesh nebulizers decreases the most common complication, cough, after flexible
bronchoscopy in children more effectively compare to jet nebulizers. Thus, mesh nebulizers may be a faster way of nebulization before
flexible bronchoscopy as an alternative to jet nebulizers.
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1. Introduction
Use of topical anesthesia prior to flexible bronchoscopy
(FB), performed to evaluate the upper airways and
tracheobronchial tree, prevents cough and stridor
during and after the procedure while reducing the need
for sedation [1,2]. In clinical practice, lidocaine is the
medication of choice for topical anesthesia before FB, due
to its short half-life and wide safety range [3]spray catheters
have been developed, allowing nebulization of the local
anesthetic solution. However, there are little data on the
efficacy and safety of this approach, or on the consumption
of sedative drugs and lidocaine during nebulized
administration. Objectives: To investigate the tolerability
of nebulized lidocaine compared to conventional lidocaine
administration via syringe through the working channel of
the bronchoscope in patients undergoing bronchoscopy.
Consumption of sedative drugs and lidocaine was also

compared between the two lidocaine administration
approaches. Methods: Patients requiring bronchoscopy
with endobronchial or transbronchial biopsy were
randomly assigned to receive topical lidocaine either via
syringe or via nebulizer. Endpoints were consumption of
lidocaine and sedative drugs, as well as patient tolerance
and safety. Results: Thirty patients were included, 15 in
each group. Patients in the nebulizer group required lower
doses of endobronchial lidocaine (184.7 ± 67.98 vs. 250.7
± 21.65 mg, p = 0.0045. Lidocaine nebulization before FB
was found to be well tolerated with better oxygenation and
fewer side effects compared to systemic administration
[4,5].
Effective delivery of aerosol drugs with a nebulizer
depends on age, physical-cognitive development, and
patient-device compatibility [6,7]ultrasonic nebulizers,
and mesh nebulizers. Newer nebulizer designs are breath-
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enhanced, breath-actuated, or have aerosol-storage bags
to minimize aerosol loss during exhalation. Nebulizers
can be used with helium-oxygen mixture and can be
used for continuous aerosol delivery. Increased attention
has recently been paid to issues related to the use of a
facemask with a nebulizer. The pressurized metered-dose
inhaler (pMDI. In addition, airway caliber, breathing rate,
inspiratory flow rate, and breathing pattern determine
the efficacy of aerosol delivery [8,9]. There are various
types of nebulizers; one is a jet nebulizer (JN), which
produces aerosol drug particles of various diameters and
requires a flow rate of 5 –6 L/min and pressure of 2 bars to
transmit these particles to the airway [10]nebulizers have
been commonly used to deliver aerosolized medications
in the treatment of patients with pulmonary diseases.
They are the aerosol device of choice when patients can
not coordinate inhalation and actuation needed for the
use of the pressurized metered-dose inhalers (pMDIs.
Noise generation between 65–100 dB is a disadvantage
for JN use in children [11]. The other type of nebulizer
is the mesh nebulizer (MN) that used a micro-pump
technology for aerosol generation without making noise
[10]nebulizers have been commonly used to deliver
aerosolized medications in the treatment of patients with
pulmonary diseases. They are the aerosol device of choice
when patients can not coordinate inhalation and actuation
needed for the use of the pressurized metered-dose inhalers
(pMDIs. MNs aerosolize the medication in liquid form by
passing it through the multiple micro-holes in a vibrating
plate [10]nebulizers have been commonly used to deliver
aerosolized medications in the treatment of patients
with pulmonary diseases. They are the aerosol device of
choice when patients can not coordinate inhalation and
actuation needed for the use of the pressurized metereddose inhalers (pMDIs. They are small, portable devices
with high output efficiency and minimal residual volume,
that work on battery or electricity. Advantages of MNs
are the efficiency of aerosol generation, constant aerosol
size, the dominantly small aerosol fraction that is suitable
to reach the peripheral airways, and nebulization of low
drug volume [10]nebulizers have been commonly used to
deliver aerosolized medications in the treatment of patients
with pulmonary diseases. They are the aerosol device of
choice when patients can not coordinate inhalation and
actuation needed for the use of the pressurized metereddose inhalers (pMDIs. MNs have minimal residual drug
volume (0.1–0.3 mL) compared to JNs and ultrasonic
nebulizers (UN) (0.8–1.5 mL) and are more efficient in
drug distribution than JNs [12,13].
The efficacy of topical lidocaine nebulization may
influence the rate and severity of post FB respiratory
symptoms such as cough and laryngeal spasm. Aerosols
generated with different nebulizer types may influence the
efficacy. Therefore, in this study, we aimed to compare the
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respiratory tract symptoms after FB between children who
received pre-procedure topical lidocaine with MNs or JNs.
2. Methods
2.1. Study population and ethics committee approval
We enrolled 4–18 years old subjects that underwent
FB due to treatment resistant asthma in Pediatric
Pulmonology and Allergy Department between January
2015 and April 2019 retrospectively in this study. Total
number of FB procedures during this time was 427 and
40 subjects fulfilled the inclusion criteria. Among these,
20 had received topical lidocaine with JN while 20 with
MN. Exclusion criteria were foreign body aspiration, short
term bronchodilator or systemic steroid use during the
previous week, congenital airway anomaly, cystic fibrosis,
primary ciliary dyskinesia neurological disease, and
cardiac disease. Moreover, subjects in which FB revealed
any pathology inconsistent wih treatment resistant asthma
were excluded.
This retrospective case-control study was approved by
the Institutional Review Board of Celal Bayar University,
School of Medicine (Date of Approval: 07.10.2019,
Number of Approval: 48).
2.2. Data collection
Age, sex, inhaler treatment used before FB, duration of
bronchoscopy, anesthetic and muscle relaxant medications
used during FB, duration of anesthesia, time to awaken
and time to recovery were recorded from procedure files
as well as croup, cough, and laryngospasm scores after FB.
After the bronchoscopy, the patients are routinely
followed up by the anesthesiologist until their vital signs
are stable and spontaneous breathing starts and time to
awaken and time to recovery are recorded in their files.
After the procedure, all cases are followed up by the
pediatric pulmonology team and group, laryngospasm
and cough scores are recorded in their files. Croup score
is calculated as the sum of retraction, airflow and cyanosis
scores, each of which are graded from 0 to 2, increasing
with severity [14]. A total score of 1–3 is mild, 4–6 is
moderate, and ≥ 7 is severe croup. Laryngospasm is scored
from one to three; just stridor (grade 1), complete closure
of vocal cords (grade 2), complete closure of vocal cords
and cyanosis (grade 3) [15]. Cough is scored as mild
(once), moderate (multiple coughs of short duration < 5
s), and severe (continuous cough > 5 s) [16]”type”:”articlejournal”,”volume”:”106”},”uris”:[“http://www.mendeley.
com/documents/?uuid=7923a422-d84b-4f11-8870-84ede
f7ffa68”]}],”mendeley”:{“formattedCitation”:”[16]”,”plainT
extFormattedCitation”:”[16]”,”previouslyFormattedCitati
on”:”[17]”},”properties”:{“noteIndex”:0},”schema”:”https://
github.com/citation-style-language/schema/raw/master/
csl-citation.json”}. Cough, laryngospasm, and croup scores
were recorded from patient files.
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2.3. Nebulization and anesthesia prior to FB
All patients received 4 mg/kg of 2% lidocaine before FB
either with JN (Hospyneb Professional, 3A Healtcare,
Italy) or MN (Aerogen Solo with Ultra, Aerogen Ltd.,
Ireland) through an age appropriate mask. The decision
to use JN or MN depended on the time left before the
procedure when the subject arrived the procedure room.
Since the JN takes a longer time to finish nebulization, the
patients who arrive to the procedure room early get their
lidocaine through a JN which takes about 10 min, but if
the time is shorter then they receive it with MN which
takes about 5 min. The nebulization was completed 5 min
before the induction of anesthesia. Nebulization times and
nebulization types of patients were recorded from their
files.
Anesthesia was induced by an anesthesiologist in
the operation room with intravenous (IV) propofol for
induction and sevoflurane inhalation for maintenance.
Use of neuromuscular blocker IV Rocuronium was
recorded from the files. FB (Fujinon EB-470S - Fujinon
EB-470P, Fujifilm Corp., Saitama, Japan) was performed
by a pediatric pulmonologist using age and weight
appropriate scopes. During the procedure, all cases were
monitored in terms of cardiac and respiratory parameters
and the bronchoscopy procedure is recorded in their files
along with a video.
2.4. Statistical analysis
In this research; data analysis was performed using
SPSS v: 15.0 (IBM Corp., Armonk, NY, USA). Statistical
analysis included descriptive statistics, Student-t test,
Pearson chi-square tests, and Mann–Whitney analysis.
Group comparisons were performed using Student t
test for continuous variables and χ2 test to compare
categorical variables. Categorical variables were reported

as frequency and percentage. Mann–Whitney U test
was used to compare continuous variables not normally
distributed between MN and JN group. A p-value of 0.05
was considered statistically significant.
3. Results
3.1. Sociodemographic characteristics
Age was not significantly different among the two groups
(8.3 ± 3.6 years in the JN group vs. 9.5 ± 4.6 years in the
MN group, p = 0.44) (Table 1).
3.2. Procedure and anesthesia
Bronchoscopy duration was not significantly different
between the two groups (8.6 ± 2.9 vs. 9.6 ± 5.4 min in
the JN and MN groups respectively, p = 0.51). Similarly,
anesthesia duration was similar (15.3 ± 6.2 and 15.9 ±
9.7 min in the JN and MN groups respectively, p = 0.88).
Awakening and recovery times were not significantly
different between the two groups, either (p = 0.10 and p =
0.22 respectively) (Table 1).
During bronchoscopy, 21 subjects received rocuronium
as a neuromuscular blocker; duration of bronchoscopy
and anesthesia, time to awaken and recovery time were
not significantly different among the subjects who received
rocuronium and who did not (p = 0.94, p = 0.06, p = 0.35
and p = 0.80 respectively). There was no difference in the
croup, laryngospasm and cough scores of the subjects that
received rocuronium or not (p = 0.73, p = 0.66, and p =
0.66, respectively).
3.3. Post-bronchoscopy respiratory symptoms
Most of the subjects enrolled had a mild croup score after
the procedure (95% in the MN and 90% in the JN groups, p
= 0.62). Similarly, majority of the subjects did not develop
any degree of laryngospasm (80% in the MN and 90% of
the JN groups, p = 0.50). On the other hand, cough was

Table 1. Sociodemographic and procedure characteristics of the study population.
MN group
(n = 20)

JN group
(n = 20)

p=

Age (years) ****

9.5 (4.6)

8.3 (3.6)

0.44*

Sex (male) *****

12(60)

8 (40)

0.34***

Bronchoscopy duration (min)****

9.6 (5.4)

8.6 (2.9)

0.51**

Anesthesia duration (min)****

15.9 (9.7)

15.3 (6.2)

0.88**

Time to awaken (min)****

7.9 (9.0)

7.6 (3.0)

0.10**

Recovery time (min)****

4.8 (1.8)

5.9 (1.8)

0.22**

*Student T test.
**Mann–Whitney U test.
*** Pearson Chi-Square.
**** Expressed as mean (SD).
*****Expressed as n (%).
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the most common post-FB respiratory symptom. Overall,
70% of the MN group had mild and 30% had moderate
cough scores but the JN group, 30% had mild, 60% had
moderate and 10% had severe cough score. On JN group;
cough score was significantly worse than the MN group (p
= 0.03) (Table 2).
4. Discussion
Flexible bronchoscopy is a method frequently used
by pediatric pulmonologists for the diagnosis of
respiratory diseases and pre-operative topical anesthesia
via nebulization is applied commonly to decrease
complications such as laryngospasm and cough [17–19].
In this study, we compared the efficacy of two different
nebulizer types in decreasing the severity of post-procedure
complications. There were no severe complications in both
JN and MN groups, but cough severity was lower in the
MN group.
Cough is the most important and common
complication in bronchoscopy with a prevalence of 27%
and it can lead to patient intolerance as well as physician
dissatisfaction [20,21]. Lidocaine with its rapid onset
of action, short half-life and a good safety profile is the
most commonly used local anesthetic agent to reduce
cough in the bronchoscopy procedure [22]. Although,
topical anesthetics carry the risk of side effects upon rapid
absorption through mucous membranes, lidocaine has
a good safety profile [23]. Thus, lidocaine nebulization
either with JN or MN is used for topical anesthesia before
FB routinely in our clinic. We did not observe any side
effects related to lidocaine nebulization in our study.
Aerosol therapy with nebulizer is frequently used
for the treatment of respiratory symptoms and there are

various nebulizer types depending on their operating
principles. Particle size and delivery rate are critical factors
in determining the local and total lung accumulation of
inhaled aerosol drugs [24]. JNs, easy to operate and cheap,
are frequently used in daily life but have disadvantages of
a large residual volume, electrical supply requirement and
noise [25]. MNs have gained popularity over the years lately
due to its low residual volume, completely silent operation,
and easy use and cleaning [26]interfaces, and flow rates
are used to deliver aerosolized medications to children.
The purpose of this study was to determine the effect of
nebulizer type, delivery interface, and flow rate on aerosol
drug delivery to spontaneously breathing pediatric and
infant lung models. Methodology: A teaching mannequin
was attached to a sinusoidal pump via a collecting filter
at the bronchi to simulate a spontaneously breathing
child (Vt: 250 mL, RR: 20 bpm and Ti: 1 second. MNs are
reported to be more efficient in delivery of aerosols to the
peripheral airways compared to JNs [27,28]. Therefore, we
aimed to evaluate the efficacy of these two nebulizers in
terms of post-FB complications. The results of our study
revealed that there was no significant difference between
JN and MN and lidocaine nebulization groups in terms of
croup score and laryngospasm score, whereas the cough
score was significantly higher in the group using JN
compared to the group using MN.
Cough is one of the most important complication
during and after bronchoscopy, that impairs the quality
and comfort of the FB procedure and impairs patient
quality of life and led to anxiety. In previous studies, the
frequency of post-FB cough has been reported to be 27%
[21]. The frequency of moderate and severe cough was
30% in MN group and 60% in the JN group in our study.

Table 2. Post FB croup, cough and laryngospasm scores of the groups.

Croup score

Cough score

Laryngospasm score

MN group
n = 20

JN group
n = 20

Mild *

19 (95)

18 (90)

Moderate *

1 (5)

1 (5)

Severe *

0 (0)

1 (5)

Mild *

14 (70)

6 (30)

Moderate *

6 (30)

12 (60)

Severe *

0 (0)

2 (10)

No *

16 (80)

18 (90)

Grade 1 *

4 (20)

1 (5)

Grade 2 *

0 (0)

1 (5)

Grade 3 *

0 (0)

0 (0)

*Values are expressed as n (%).
** Pearson Chi-square.
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p=

0.62 **

0.03 **

0.50 **
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This difference may be attributed to the standard particle
size and efficient distribution of these particles to the
peripheral airways with MNs compared to JNs. Moreover,
shorter total duration of nebulization may increase patient
adherence to the technique.
The current study has a few limitations. Due to the
limited number of mesh nebulizers, the priority of jet
nebulizer for routine lidocaine nebulization causes a
limited number of patients who receive lidocaine with
mesh nebulizer. For this reason, the number of patients
who are applied lidocaine with a mesh nebulizer between
the research years and who meet the research criteria

is limited. A prospective, double-blind study with two
groups with a higher number of subjects using JN or MN
may add value to the research.
In conclusion, MNs may be used as an alternative to
JN for pre-FB local anesthetic administration to decrease
cough severity during and post-FB in children. Silent and
short duration of nebulization are the advantages of this
technique.
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